EGFR Mutation Status and PD-L1 Expression in Patients ≤40 Years Old with NSCLC

EGFR Mutation Status and PD-L1 Expression in Patients ≤40 Years Old with NSCLC

Objective To retrospectively analyze the clinical data of 47 young NSCLC patients mutation style of EGFR and PD-L1 expression in tumor cells, to understand their clinicopathological and molecular characteristics. Methods We enrolled 47 young (≤40 years old) patients confirmed as NSCLC who underwent...

全面介绍

书目详细资料
Main Authors: HU Mingming, LIU Zichen, ZHANG Hongmei, LU Baohua, LI Jie, WANG Qunhui, HU Fanbin, LIN Haifeng, LI Baolan, ZHANG Tongmei
格式: 文件
语言:zho
出版: Magazine House of Cancer Research on Prevention and Treatment 2022-07-01
丛编:Zhongliu Fangzhi Yanjiu
主题:
nsclc
young(≤40 years old)
egfr
pd-l1
在线阅读:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.0969

因特网

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.0969

相似书籍